跳至主要内容
临床试验/NCT02935335
NCT02935335已完成不适用

Relationship Between antimüllerian Hormone Measured by a Fully Automated Assay and the Initial Dose of HP-hMG (Menopur®) Prescribed for Infertile Women Undergoing Their First IVF/ICSI Cycle.

Ferring Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 297 人开始时间: 2016年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
297
试验地点
1
主要终点
Spearman correlation coefficient between Menopur® 600 IU/mL dose and AMH serum levels

研究概览

简要总结

AME is a non-interventional, prospective, longitudinal and multicenter study. This study aims to measure the relationship between antimüllerian hormone serum level (AMH), as measured by a fully automated assay and the initial dose of Menopur® HP-hMG 600 IU/mL prescribed for infertile women undergoing their first IVF/ICSI cycle in the current practice.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women aged between [18-42] years.
  • Both ovaries present.
  • Regular menstrual cycles presumed to be ovulatory.
  • Primary or secondary infertility of any origin for more than 12 months.
  • Patient with at least one result of antimüllerian hormone (AMH) measured by a fully automated assay available before inclusion, and performed in the past 12 months before inclusion.
  • Candidates eligible to a first IVF/ICSI cycle and for whom Menopur® HP-hMG 600 IU/mL has been prescribed.
  • Having received oral and written information on the study, without any objections for the use of his/her anonymized data, and having signed a written Informed Consent Form.

排除标准

  • Major uterine or ovarian morphological abnormalities or past ovarian surgery.
  • Endometriosis stage III/IV.
  • Polycystic ovarian syndrome.
  • Major endocrine or metabolic abnormalities without treatment.
  • Patient included in an interventional study assessing treatment for infertility.

研究组 & 干预措施

Menopur® HP-hMG

Treatment according to routine clinical practice.

干预措施: Menotrophin (Drug)

结局指标

主要结局

Spearman correlation coefficient between Menopur® 600 IU/mL dose and AMH serum levels

时间窗: At baseline (inclusion)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study to Measure Relationship Between... | 临床试验